Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesMRIResting-state fMRI analysis reveals impact of blast exposuresA study of active and veteran U.S. special operations forces cohorts confirms how regions of the brain become altered.MRIMRI radiomics model predicts risk in women with DCISUltrasoundAIUM: Ob/gyn gaining ground on radiology in gynecologic ultrasoundUltrasoundAIUM: POCUS residency tracks improve skills for family med specialistsSponsor ContentElevate your patient's care with the capabilities of Cardiac PET/CT